Unique Ingredient Identifier 4R4HFI6D95 is listed as a ingredient substance
| RN | 25322-68-3 |
| NCIT | C84081 |
| RXCUI | 1310594 |
| MF | Polymer substance not supported |
UNII 4R4HFI6D95 POLYETHYLENE GLYCOL 4000 is commonly included in medications in the following forms.
| Route | Dosage Form | Potency |
|---|---|---|
| AURICULAR (OTIC) | SUSPENSION | NA |
| DENTAL | OINTMENT | NA |
| INTRA-ARTICULAR | INJECTION | 3 % |
| INTRALESIONAL | INJECTION | 3 % |
| INTRAMUSCULAR | INJECTION | 3 % |
| INTRAMUSCULAR | SUSPENSION | 3 % |
| INTRAMUSCULAR | SUSPENSION, EXTENDED RELEASE | 7.5 % |
| INTRAMUSCULAR | SUSPENSION, INJECTION | 4.5 % |
| INTRAMUSCULAR | SUSPENSION, INJECTION | 4.5 %W/V |
| INTRASYNOVIAL | INJECTION | 3 % |
| INTRAVENOUS | INJECTION, SUSPENSION | 0.49 % |
| OPHTHALMIC | SUSPENSION | NA |
| ORAL | CAPSULE | 380.5 MG |
| ORAL | CAPSULE, DELAYED ACTION | 2.55 MG |
| ORAL | CAPSULE, DELAYED RELEASE | 1.28 MG |
| ORAL | CAPSULE, ENTERIC COATED PELLETS | 96.19 MG |
| ORAL | CAPSULE, EXTENDED RELEASE | 10.72 MG |
| ORAL | CAPSULE, SOFT GELATIN | 15 MG |
| ORAL | GRANULE | 83 MG/1PKT |
| ORAL | SOLUTION | 66.67 MG/1ML |
| ORAL | TABLET | 15 MG |
| ORAL | TABLET (IMMED./COMP. RELEASE), FILM COATED | 1.5 MG |
| ORAL | TABLET, COATED | 2 MG |
| ORAL | TABLET, DELAYED ACTION | 1.05 MG |
| ORAL | TABLET, DELAYED ACTION, ENTERIC COATED | 0.96 MG |
| ORAL | TABLET, EXTENDED RELEASE | 216.5 MG |
| ORAL | TABLET, FILM COATED | 4.2 MG |
| ORAL | TABLET, MULTILAYER, EXTENDED RELEASE | 2.8 MG |
| ORAL | TABLET, SUSTAINED ACTION | 454 MG |
| ORAL | TABLET, SUSTAINED ACTION, FILM COATED | 1.8 MG |
| RECTAL | SUPPOSITORY | 1269 MG |
| SOFT TISSUE | INJECTION | NA |
| SUBLINGUAL | TABLET | 2.5 MG |
| TOPICAL | EMULSION, CREAM | NA |
| TOPICAL | OINTMENT | 45 %W/W |
| TOPICAL | SOLUTION | NA |
| VAGINAL | EMULSION, CREAM | 0.5 % |
| VAGINAL | SUPPOSITORY | NA |